Marker Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Marker Therapeutics has a total shareholder equity of $14.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $17.1M and $3.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$15.11m |
Equity | US$14.05m |
Total liabilities | US$3.07m |
Total assets | US$17.13m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GX1's short term assets ($17.1M) exceed its short term liabilities ($3.1M).
Long Term Liabilities: GX1 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: GX1 is debt free.
Reducing Debt: GX1 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GX1 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: GX1 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 14.1% each year